FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dayse Lourenço

Research Profile

Disorders

Geographic Areas

Brazil

Concepts & Ideas

Chemicals & Drugs

Phenomena

Prothrombin Time

Physiology

Anatomy

Blood Platelets

Co-author Network

Publications

TOP 3
Marinez Farana Matos; Christiane Pereira Gouveia; Dayse M Lourenço; Cristina Mary Orikaza; Vânia Maris Morelli
Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6.
André Fernandes d'Alessandro; Fabio Luiz de Menezes Montenegro; Sérgio de Almeida Toledo; Dayse M Lourenço; Lenine Garcia Brandão; Anói Castro Cordeiro
Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
Dayse M Lourenço; Fabio Luiz de Menezes Montenegro; Rodrigo A Toledo; Flavia L Coutinho; Tatiana Denck Gonçalves; Sergio P A Toledo
Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dayse Lourenço (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marinez Farana Matos; Christiane Pereira Gouveia; Dayse M Lourenço; Cristina Mary Orikaza; Vânia Maris Morelli
Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6.
Metabolic syndrome and related disorders 2013;11(1):29-34.
2012: André Fernandes d'Alessandro; Fabio Luiz de Menezes Montenegro; Sérgio de Almeida Toledo; Dayse M Lourenço; Lenine Garcia Brandão; Anói Castro Cordeiro
Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
Revista da Associação Médica Brasileira (1992) 2012;58(3):323-7.
2012: Dayse M Lourenço; Fabio Luiz de Menezes Montenegro; Rodrigo A Toledo; Flavia L Coutinho; Tatiana Denck Gonçalves; Sergio P A Toledo
Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
Clinics (São Paulo, Brazil) 2012;67 Suppl 1():99-108.
2012: Rodrigo A Toledo; Flavia L Coutinho; Viviane C Longuini; Dayse M Lourenço; Tomoko Sekiya; Sergio P A Toledo
Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil.
Clinics (São Paulo, Brazil) 2012;67 Suppl 1():3-6.
2012: Rodrigo A Toledo; Sergio P A Toledo; Fabio Faucz; Maria C B V Fragoso; Anelia Horvath; Viviane C Longuini; Dayse M Lourenço; Tomoko Sekiya; Constantine A Stratakis
Assessing the emerging oncogene protein kinase C epsilon as a candidate gene in families with Carney complex-2.
Clinical endocrinology 2012;76(1):147-8.
2011: Marinez F Matos; João A H Bajerl; Dayse M Lourenço; Maria A E Noguti; Cristina M Orikaza; Vânia M Morelli
The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: a case-control study.
Thrombosis research 2011;128(3):216-20.
2010: Dayse M Lourenço; Flavia L Coutinho; Rodrigo A Toledo; Fabio Luiz de Menezes Montenegro; Joya E M Correia-Deur; Sergio P A Toledo
Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(11):2382-91.
2010: Flavia L Coutinho; Dayse M Lourenço; Rodrigo A Toledo; Fabio Luiz de Menezes Montenegro; Joya E M Correia-Deur; sergio toledo
Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
Clinical endocrinology 2010;72(4):462-8.
2010: Rodrigo A Toledo; Dayse M Lourenço; Sergio P A Toledo
Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Frontiers of hormone research 2010;38():77-86.
2009: Renato D Lopes; Richard C Becker; David Garcia; Elaine M Hylek; Christopher B Granger; Dayse M Lourenço; Helena B Nader; Francisco H A Maffei; Fernando Cesena; José C Nicolau; Ari Timmerman; Ana T Rocha; Edison F de Paiva; Helio P Guimaraes; Antonio C Carvalho; Elbio A D'Amico; Carlos A Moreira-Filho; José M Aldrighi; Antonio C Lopes
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil.
Journal of thrombosis and thrombolysis 2009;28(1):106-16.
2009: Joya Emilie M Correia-Deur; Rodrigo A Toledo; Alice T Imazawa; Dayse M Lourenço; Marilza C L Ezabella; Marcos Roberto Tavares; sergio toledo
Sporadic medullary thyroid carcinoma: clinical data from a university hospital.
Clinics (São Paulo, Brazil) 2009;64(5):379-86.
2009: L A Köpke-Aguiar; C P de Leon; D C Shigueoka; Dayse M Lourenço; M Kouyomdjian; Durval Rosa Borges
Reticulated platelets and thrombopoietin in schistosomiasis patients.
International journal of laboratory hematology 2009;31(1):69-73.
2009: sergio toledo; Dayse M Lourenço; Marcelo Augusto Santos; Marcos Roberto Tavares; Rodrigo A Toledo; Joya Emilie de Menezes Correia-Deur
Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
Clinics (São Paulo, Brazil) 2009;64(7):699-706.
2008: Dayse M Lourenço; R A Toledo; I I Mackowiak; F L Coutinho; M G Cavalcanti; J E M Correia-Deur; Fabio Luiz de Menezes Montenegro; Sheila Aparecida Coelho Siqueira; L C Margarido; marcel machado; sergio toledo
Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(3):259-74.
2007: claudio bonduki; Dayse M Lourenço; Eduardo L A da Motta; José Maria Soares Jr; Mauro Abi Haidar; Edmund C Baracat
Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women.
Clinics (São Paulo, Brazil) 2007;62(5):553-60.
2007: Rodrigo A Toledo; Pedro H S Correa; Flavia L Coutinho; Malebranche B C Cunha-Neto; Bernardo Liberman; Dayse M Lourenço; Marcel C C Machado; Ivone Mackowiack; Fabio Luiz de Menezes Montenegro; Maria A A Pereira; Elisangela Quedas; Sergio P A Toledo
Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1.
Clinical endocrinology 2007;67(3):377-84.
2007: Vânia Maris Morelli; Celso Arrais Rodrigues; M A E Noguti; Marinez Farana Matos; Raniely Casimiro da Silveira; Aline Amorim Martinez Ribeiro; Dayse M Lourenço
Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(5):401-5.
2007: Fabiano Pieroni; Dayse M Lourenço; Vânia M Morelli; Francisco H A Maffei; Marco Zago; Rendrik F Franco
Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY).
Thrombosis research 2007;120(2):221-9.
2007: Celso Arrais Rodrigues; Vânia Maris Morelli; R C DA Silveira; V D'Almeida; Dayse M Lourenço
Homocysteine reduction by B-vitamin supplementation increases t-PA and PAI-1 levels in patients with venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2007;5(1):195-8.
2007: Ana C Pereira; Dayse M Lourenço; Francisco H A Maffei; Vânia M Morelli; Hamilton A Rollo; Marco Zago; Hélio Vannucchi; Rendrik F Franco
A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study).
Thrombosis research 2007;119(2):183-8.
2006: André Carvalho Felício; Marcia Maiumi Fukujima; Jose Antônio Fiorot; Gilmar Fernandes do Prado; Roberto Carvalho-Filho; Celso Arrais Rodrigues; Vânia Maris Morelli; Dayse M Lourenço
Cerebral venous thrombosis and hepatitis: case report.
Arquivos de neuro-psiquiatria 2006;64(4):1041-2.
2006: F Moreira Neto; Dayse M Lourenço; M A E Noguti; Vânia Maris Morelli; I C P Gil; A C S Beltrão; Maria Stella Figueiredo
The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2006;39(10):1291-5.
2005: José Antonio Fiorot Júnior; André Carvalho Felício; Marcia Maiumi Fukujima; Celso Arrais Rodrigues; Vânia Maris Morelli; Dayse M Lourenço; Gilmar F Prado
Tuberculosis: an uncommon cause of cerebral venous thrombosis?
Arquivos de neuro-psiquiatria 2005;63(3B):852-4.
2004: Celso Arrais Rodrigues; L K A Rocha; Vânia Maris Morelli; Rendrik F Franco; Dayse M Lourenço
Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1211-2.
2004: Sheila Soares; Hélio Moraes-Souza; Maria Aparecida Vieira Tostes; Dayse M Lourenço
[Effects of two trypanosomicide drugs, gention violet and WR6026, on platelet concentrates preservation].
Revista da Sociedade Brasileira de Medicina Tropical 2004;37(3):248-51.
2003: Paulo S Massabki; Neusa P Silva; Dayse M Lourenço; L E C Andrade
Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
The Journal of rheumatology 2003;30(12):2606-12.
2003: Marlene Zannin; Dayse M Lourenço; Guacyara Motta; Luis R Dalla Costa; Margaret Grando; Geni P Gamborgi; M A E Noguti; Ana Marisa Chudzinski-Tavassi
Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, southern Brazil.
Thrombosis and haemostasis 2003;89(2):355-64.
2002: Vânia Maris Morelli; Dayse M Lourenço; V D'Almeida; Rendrik F Franco; F Miranda; Marco Zago; M A E Noguti; E Cruz; José Kerbauy
Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(3):271-5.
2001: Ana Marisa Chudzinski-Tavassi; Mirta Schattner; Márcio Fritzen; Roberto Gabriel Pozner; Cleyson Valença Reis; Dayse M Lourenço; María A Lazzari
Effects of lopap on human endothelial cells and platelets.
Haemostasis 2001;31(3-6):257-65.
2001: Rendrik F Franco; M G Fagundes; J C Meijers; P H Reitsma; Dayse M Lourenço; Vânia Maris Morelli; Francisco H A Maffei; I C Ferrari; Carlos E Piccinato; Wilson Araújo Silva Jr; Marco Zago
Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
Haematologica 2001;86(5):510-7.
1999: Rendrik F Franco; P H Reitsma; Dayse M Lourenço; Francisco H A Maffei; Vânia Maris Morelli; Marli H Tavella; AG Araújo; Carlos E Piccinato; Marco Zago
Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Thrombosis and haemostasis 1999;81(5):676-9.
1999: Rendrik F Franco; Vânia Maris Morelli; Dayse M Lourenço; Francisco H A Maffei; Marli H Tavella; Carlos E Piccinato; IA Thomazini; Marco Zago
A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease.
British journal of haematology 1999;105(2):556-9.
1998: Rendrik F Franco; Francisco H A Maffei; Dayse M Lourenço; Vânia Maris Morelli; IA Thomazini; Carlos E Piccinato; Marli H Tavella; Marco Zago
Factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in venous thrombotic disease.
British journal of haematology 1998;103(3):888-90.
1998: R Franco; Francisco H A Maffei; Dayse M Lourenço; Carlos E Piccinato; Vânia Maris Morelli; IA Thomazini; M Zago
The frequency of 844ins68 mutation in the cystathionine beta-synthase gene is not increased in patients with venous thrombosis.
Haematologica 1998;83(11):1006-8.
1998: claudio bonduki; Dayse M Lourenço; Edmund C Baracat; Mauro Abi Haidar; M A E Noguti; E L da Motta; GR Lima
Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
Acta obstetricia et gynecologica Scandinavica 1998;77(3):330-3.
1998: Dayse M Lourenço; Vânia Maris Morelli; CV Vignal
[Treatment for overdose of oral anticoagulants].
Arquivos brasileiros de cardiologia 1998;70(1):9-13.
1997: CV Vignal; Dayse M Lourenço; M A E Noguti; Maria de Lourdes L F Chauffaille; José Kerbauy
Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.
São Paulo medical journal = Revista paulista de medicina 1997;115(6):1575-9.
1997: A A Ribeiro; Dayse M Lourenço; Carlos F Toledo; M A E Noguti; Durval Rosa Borges
[Antithrombin III concentrate use in patients with cirrhosis with coagulation disorders].
Revista da Associação Médica Brasileira (1992) 1997;43(3):189-94.
1997: Dayse M Lourenço; L H Lopes; CV Vignal; Vânia Maris Morelli
[Clinical and laboratory evaluation of patients treated with oral anticoagulation].
Arquivos brasileiros de cardiologia 1997;68(5):353-6.
1997: Dayse M Lourenço; R M Santana; CV Vignal
Pregnancy in patients with immune thrombocytopenic purpura.
Haematologica 1997;82(3):383-4.
1995: Dayse M Lourenço; M A E Noguti; L Juliano
[Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations].
Revista da Associação Médica Brasileira (1992) 1995;41(6):373-8.
1995: Dayse M Lourenço; E de C Alves
[Laboratory control of oral anticoagulation].
Revista da Associação Médica Brasileira (1992) 1995;41(2):103-8.
1989: José Orlando Bordin; José Kerbauy; Dayse M Lourenço; R Sesso
Level of fetal hemoglobin as an indicator of clinical complications in sickle cell anemia.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1989;22(11):1347-53.